Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
The following section summarizes insights on H Lundbeck B's EPS Diluted Cumulative Growth (3y):
We've identified the following companies as similar to H Lundbeck B because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
Name | Ticker | EPS Diluted Cumulative Growth (3y) |
---|---|---|
Pfizer Inc | DB:PFE | -64.1% |
Ipsen SA | ENXTPA:IPN | -43.6% |
Novartis AG | SWX:NOVN | -42.1% |
Roche Holding AG | SWX:RO | -36.3% |
GSK plc | DB:GS71 | -24.0% |
Sanofi SA | ENXTPA:SAN | -11.3% |
Healthcare | SECTOR:HLTH.DK | 63.8% |
Orion Oyj A | HLSE:ORNAV | 70.3% |
Novo Nordisk A/S Class B | CPSE:NOVOB | 118.2% |
Almirall | BME:ALM | 120.9% |
H Lundbeck B | CPSE:HLUNB | 138.9% |
AstraZeneca PLC | OM:AZN | 5,597.4% |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EPS Diluted Cumulative Growth (3y) in the growth category include:
Cumulative diluted EPS growth over the last three years
The chart above depicts the distribution of EPS Diluted Cumulative Growth (3y) for companies operating in the Healthcare Sector in the Developed economic region. Over 2,260 companies were considered in this analysis, and 2,178 had meaningful values. The average EPS Diluted Cumulative Growth (3y) of companies in the Sector is -21.2% with a standard deviation of 180.5%. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
H Lundbeck B's EPS Diluted Cumulative Growth (3y) of 138.9% ranks in the 95.4% percentile for the Sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,268 |
Included Constituents | 2,178 |
Min | -1,330.2% |
Max | 332.8% |
Median | 27.0% |
Mean | -21.2% |
Standard Deviation | 180.5% |
You can find companies with similar EPS Diluted Cumulative Growth (3y) using this stock screener.